GALAXY Study: Postoperative ctDNA as a Prognostic and Predictive Biomarker in Stage II–III Rectal Cancer
Insilico and Servier Strike Up to 888 Million Dollar AI Oncology Drug Discovery Deal
Call for Papers: Special Series on Gastrointestinal Oncology in 2026
Guillermo Rivell: Excited to Begin My Role as Senior Medical Director at AbbVie
The 100 Most Influential People in Oncology in 2025 (Full List)
Douglas Flora: The Other KPI—Measuring Patient Suffering Burden in Cancer Care
What's Next in Cancer Care? Key Oncology Advances to Watch in 2026
The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a thorough understanding of current standards of care, molecular pathology, and novel treatment targets. The preceptorship will take place on February 18–19, 2026, in Lugano, Switzerland, […]
The ESMO Preceptorship on Hereditary Cancer Genetics 2026 is an intensive educational course scheduled for May 11–12, 2026, in Lugano, Switzerland. Co-chaired by Judith Balmaña and Marjolijn Ligtenberg, this program […]
The ESMO Preceptorship on Head and Neck Cancer 2026 is a specialized educational course scheduled for May 13–14, 2026, in Lugano, Switzerland. This program is designed to provide medical and […]
The ESMO Preceptorship on Colorectal Cancer 2026: Lugano is a specialized educational course scheduled for May 15–16, 2026, in Lugano, Switzerland. This course is designed to provide oncologists - particularly young and general oncologists - with a comprehensive understanding of colorectal cancer management from diagnosis to treatment. The technical program includes plenary lectures by international […]